Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study

and for the ERIVANCE BCC Investigators

Research output: Contribution to journal › Article › peer-review

141 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study'. Together they form a unique fingerprint.

Medicine & Life Sciences